Welcome to Markets Desk, here's what's moving the needle right now.
The World Health Organization has declared the Ebola outbreak in Congo and Uganda a global health emergency of international concern. With three hundred thirty six suspected cases and eighty eight deaths already reported, the strain in question has no approved treatments, making containment the only viable strategy at this stage. Markets will be watching pharmaceutical and biotech names closely.
Shifting to tech and capital markets, Broadcom has crossed the two trillion dollar valuation threshold, and private credit giants are reportedly in talks to extend significant debt financing to the chipmaker. That kind of institutional appetite signals confidence in Broadcom's AI infrastructure runway, but it also raises questions about leverage at the top of a very extended cycle.
And in fintech, Robinhood, SoFi, and Webull are telling sharply divergent stories heading into the back half of the year. Investors are peeling apart the growth narratives, scrutinizing profitability timelines and long-term risk profiles with far more discipline than they showed during the retail trading boom. The easy money thesis for this sector is clearly under pressure.
That's the tape. Markets Desk, signing off the floor.
